Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle
Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle


Feb. 8, 2021 -- Illumina, Inc. (NASDAQ: ILMN) has selected nine new genomics companies to join the second global funding cycle of Illumina Accelerator in the U.S. and UK. The global company

ProvideGx® Partners with Apotex Corp. to Stabilize Supply of Three Vital Antibiotics: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
ProvideGx® Partners with Apotex Corp. to Stabilize Supply of Three Vital Antibiotics


Premier Inc. (NASDAQ: PINC), through its ProvideGx® program, has partnered with Apotex Corp. to supply three essential antibiotics to healthcare providers, helping to secure the immediate and

6 der 7 weltweit führenden Auftragsforschungsunternehmen kooperieren mit Veeva zur schnelleren Durchführung klinischer Studien für Sponsoren
6 der 7 weltweit führenden Auftragsforschungsunternehmen kooperieren mit Veeva zur schnelleren Durchführung klinischer Studien für Sponsoren


Veeva Systems (NYSE: VEEV) gab heute bekannt, dass sechs der sieben weltweit führenden Auftragsforschungsunternehmen dem Veeva Vault CDMS-Partnerprogramm beigetreten sind. Die Beschleunigung der

Lantheus Holdings Announces Presentations Featuring its PSMA-Targeted Pipeline Product Candidates at the 2021 ASCO GU Annual Meeting
Lantheus Holdings Announces Presentations Featuring its PSMA-Targeted Pipeline Product Candidates at the 2021 ASCO GU Annual Meeting


Lantheus Holdings, Inc. (NASDAQ: LNTH) (the “Company”), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture

6 of the Top 7 Global CROs Partner With Veeva to Run Faster Clinical Trials for Sponsors
6 of the Top 7 Global CROs Partner With Veeva to Run Faster Clinical Trials for Sponsors


Veeva Systems (NYSE: VEEV) today announced that 6 out of the top 7 global CROs have joined the Veeva Vault CDMS partner program. Accelerating clinical research is a top priority in the life

6 of the Top 7 Global CROs Partner with Veeva to Run Faster Clinical Trials for Sponsors
6 of the Top 7 Global CROs Partner with Veeva to Run Faster Clinical Trials for Sponsors


Veeva Systems (NYSE: VEEV) today announced that 6 out of the top 7 global CROs have joined the Veeva Vault CDMS partner program. Accelerating clinical research is a top priority in the life

Illumina Supports National Program to Evaluate Potential of Comprehensive Genomic Profiling in Late Stage Cancer Real-World Setting Across Belgium
Illumina Supports National Program to Evaluate Potential of Comprehensive Genomic Profiling in Late Stage Cancer Real-World Setting Across Belgium


February 4, 2021 -- Today, Illumina, Inc. (NASDAQ:ILMN) announced an agreement with the Belgian Society of Medical Oncology (BSMO) which is running a new national pilot to evaluate the use of

Epredia setzt Veeva MedTech-Lösungen zur Vereinheitlichung der Änderungskontrolle in den Bereichen Qualität und Regulierung ein
Epredia setzt Veeva MedTech-Lösungen zur Vereinheitlichung der Änderungskontrolle in den Bereichen Qualität und Regulierung ein


Veeva Systems (NYSE: VEEV) gab heute bekannt, dass Epredia, ein weltweit führender Anbieter im Bereich der Präzisionsdiagnostik für Krebs und Gewebe, die Anwendungen Veeva Vault Quality und Veeva

Quidel Opens New Manufacturing Facility to Mass Produce QuickVue® Rapid Antigen Tests for COVID-19
Quidel Opens New Manufacturing Facility to Mass Produce QuickVue® Rapid Antigen Tests for COVID-19


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, today announced the opening

Chemed To Report Fourth-Quarter 2020 Earnings February 23, Related Conference Call To Be Held On February 24
Chemed To Report Fourth-Quarter 2020 Earnings February 23, Related Conference Call To Be Held On February 24


Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2020, on Tuesday, February 23, 2021, following the close of trading on

Epredia Adopts Veeva MedTech Solutions to Unify Change Control Across Quality and Regulatory
Epredia Adopts Veeva MedTech Solutions to Unify Change Control Across Quality and Regulatory


Veeva Systems (NYSE: VEEV) today announced that Epredia, a global leader in precision cancer and tissue diagnostics, is adopting Veeva Vault Quality and Veeva Vault RIM applications to automate

Epredia Adopts Veeva MedTech Solutions to Unify Change Control Across Quality and Regulatory
Epredia Adopts Veeva MedTech Solutions to Unify Change Control Across Quality and Regulatory


Veeva Systems (NYSE: VEEV) today announced that Epredia, a global leader in precision cancer and tissue diagnostics, is adopting Veeva Vault Quality and Veeva Vault RIM applications to automate

PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2020: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24701/263px-PerkinElmer.svg.png
PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2020


PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the fourth quarter and full year ended January 3, 2021.



Fourth

Dexcom und Nick Jonas enthüllen den ersten Super Bowl-Werbespot und fordern eine bessere Versorgung von Menschen mit Diabetes
Dexcom und Nick Jonas enthüllen den ersten Super Bowl-Werbespot und fordern eine bessere Versorgung von Menschen mit Diabetes


DexCom, Inc. (NASDAQ:DXCM), der weltweit führende Anbieter von kontinuierlicher Blutzuckermessung für Menschen mit Diabetes, hat heute seinen allerersten Super-Bowl-Werbespot mit dem

Dexcom and Nick Jonas Unveil First-Ever Super Bowl Commercial, Calling for Better Care for People With Diabetes
Dexcom and Nick Jonas Unveil First-Ever Super Bowl Commercial, Calling for Better Care for People With Diabetes


DexCom, Inc. (NASDAQ:DXCM), the global leader in continuous glucose monitoring for people with diabetes, debuted today its first-ever Super Bowl commercial, starring multi-platinum recording

AMN Healthcare Achieves High Ranking in LGBTQ Corporate Equality Index
AMN Healthcare Achieves High Ranking in LGBTQ Corporate Equality Index


AMN Healthcare (NYSE: AMN) received a top ranking – 95 out of 100 – in the Human Rights Campaign Foundation’s 2021 Corporate Equality Index, the nation’s foremost survey measuring corporate

Simulations Plus Enters Agreement with Distributor in China: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Enters Agreement with Distributor in China


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it

Premier, Inc. Reports Fiscal-Year 2021 Second-Quarter Results: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier, Inc. Reports Fiscal-Year 2021 Second-Quarter Results


Premier, Inc. (NASDAQ: PINC) today reported financial results for the fiscal year (FY) 2021 second quarter ended December 31, 2020 and announced its fiscal 2021 financial guidance.



All results

Premier Inc. President Michael J. Alkire to Succeed Susan DeVore as Chief Executive Officer: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier Inc. President Michael J. Alkire to Succeed Susan DeVore as Chief Executive Officer


Premier Inc. (NASDAQ: PINC) today announced that after nearly 18 years of distinguished service, Susan DeVore is retiring as the company’s chief executive officer and a member of its Board of

DispatchHealth and Humana Team Up to Provide Hospital-Level Care in the Home: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
DispatchHealth and Humana Team Up to Provide Hospital-Level Care in the Home


Humana Inc., a leading health and well-being company, and DispatchHealth, a provider of in-home medical care, today announced an agreement to provide Humana members with access to an advanced level

Agilent Wins Trade Secret and Patent Infringement Litigation
Agilent Wins Trade Secret and Patent Infringement Litigation


Agilent Technologies Inc. (NYSE: A) today announced it has won a judgement in federal court for patent infringement and trade secret misappropriation against Shanghai-based J&X Technologies. The

AMN Healthcare Achieves Top Ranking Among Healthcare Companies in Bloomberg Gender-Equality Index
AMN Healthcare Achieves Top Ranking Among Healthcare Companies in Bloomberg Gender-Equality Index


AMN Healthcare (NYSE: AMN) is one of 380 companies across 11 industry sectors and 44 countries included in the 2021 Bloomberg Gender-Equality Index (GEI). In the healthcare sector, AMN Healthcare

Illumina and Sequoia Capital China Partner to Launch Genomics Incubator in China
Illumina and Sequoia Capital China Partner to Launch Genomics Incubator in China


January 31, 2021—Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Sequoia Capital China, a leading investment firm, today announced a

Quidel to Hold Fiscal Fourth Quarter and Full Year 2020 Financial Results Conference Call on February 18th, 2021
Quidel to Hold Fiscal Fourth Quarter and Full Year 2020 Financial Results Conference Call on February 18th, 2021


Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report fiscal fourth quarter and

PerkinElmer Board Declares Quarterly Dividend: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24701/263px-PerkinElmer.svg.png
PerkinElmer Board Declares Quarterly Dividend


The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock January 28, 2021. This dividend is payable on May 7, 2021 to all